Enzymatica publ AB
Research Enzymatica publ AB (ENZY) on Bullrun: market cap SEK 461.20M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerENZY
- ExchangeST
- CountrySweden
- SectorHealthcare
- IndustryDrug Manufacturers - Specialty & Generic
- CurrencySEK
- Market capSEK 461.20M
- Financial periodQ2 2026
- RevenueSEK 7.15M
- Net income-SEK 12.97M
- Free cash flow-SEK 11.69M
- Gross margin45.3%
Valuation Snapshot
latest market cap is SEK 461.20M.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | SEK 53.91M | -SEK 51.93M | n/a | 61.4% | n/a | SEK 33.13M | SEK 1.02M | SEK 124.17M |
| FY2024 | SEK 45.58M | -SEK 52.67M | n/a | 67.4% | n/a | SEK 75.21M | SEK 2.20M | SEK 176.37M |
| FY2023 | SEK 50.90M | -SEK 48.95M | n/a | 62.6% | n/a | SEK 8.37M | n/a | n/a |
| FY2022 | SEK 48.95M | -SEK 68.55M | n/a | 58.1% | n/a | SEK 50.69M | n/a | n/a |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-08-25 | SEK 461.20M | n/a | n/a | 0 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 0 SEK.
About Enzymatica publ AB
Enzymatica AB (publ), a life science company, develops and sells medical devices for infectious diseases. The company's product includes ColdZyme, a mouth spray that protects against the upper respiratory viruses that can cause cold and flu symptoms. It also provides enzyme formulations for skin care under Penzyme technology. The company was incorporated in 2007 and is headquartered in Lund, Sweden.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Enzymatica publ AB's market cap?
Enzymatica publ AB's market capitalization is SEK 461.20M.
What does Enzymatica publ AB do?
Enzymatica AB (publ), a life science company, develops and sells medical devices for infectious diseases. The company's product includes ColdZyme, a mouth spray that protects against the upper respiratory viruses that can cause cold and flu symptoms. It also provides enzyme formulations for skin care under Penzyme technology. The company was incorporated in 2007 and is headquartered in Lund, Sweden.